Edwards Lifesciences Corporation Common Stock vs MACOM Technology — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while MACOM Technology trades at $326 (market cap $25.65B). The key difference: Edwards Lifesciences Corporation Common Stock is the larger of the two by market cap, and MACOM Technology is trading nearer its 52-week high, Edwards Lifesciences Corporation Common Stock nearer its low. Which is the better fit depends on your goals.
| EW | MTSI | |
|---|---|---|
Market Cap | $49.44B | $25.65B |
Volume | 3,508,027 | 1,518,856 |
Sector | Health | Technology |
52-Week High | $95.18 | $409.68 |
52-Week Low | $72.65 | $122.18 |
Enterprise Value | $45.90B | $25.37B |
Typical Hold Time | — | 6 Days |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →MACOM develops analog, radio frequency, microwave, and optical semiconductors. Its components are used in telecommunications, data centers, industrial systems, aerospace, and defense applications.
Read more on MTSI →